Supportive Medicines Phase 5a - Propofol 1g/50ml Emulsion for Infusion
key details
| Status | complete |
|---|---|
| Category (CPV) | 33600000 |
| Procedure | limited |
| OCID | ocds-h6vhtk-031874 |
Awards (3)
This procurement was awarded to 2 suppliers. Values shown are per-award; the notice total is ·.
| Supplier | Value | Date | Status |
|---|---|---|---|
| B. Braun Medical Limited | £1 | 23 Jan 2022 | active |
| B. Braun Medical Limited | · | · | active |
| B. BRAUN MEDICAL LIMITED | £1 | 23 Jan 2022 | active |
description
A requirement for the supply of 375,000 vials of Propofol 1g / 50 ml emulsion for infusion (for use in Intensive Treatment Units) in preparation for further waves of Covid 19 in Winter 2021/Spring 2022.
notice history
2 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 17 Feb 2022 | Contract award notice (F03) | Earlier regulations | 004568-2022 |
| 29 Nov 2022 | Award (award) | · | a17b61a1-f145-4c0d-8909-6a489d77bb7d-594192 |
more from Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
- Under-18 SARS-CoV-2 Vaccine Supply (2026) · £1,000,000,000 · 2 Jul 2026
- Live Attenuated Influenza Vaccine 2026/2027 · 19 Jun 2026
- IHR Strengthening Events and Logistics Management and Technical Assistance - Pakistan · £4,018,608 · 28 May 2026
- Centralised Adult Flu Procurement · 27 Apr 2026
- PHE_Scientific_Appointment of CDMO for vaccine production · 22 Apr 2026
- European Viper Antivenom (2024) · 22 Apr 2026
- Varicella-zoster immunoglobulin (VZIG) 2025 · 22 Apr 2026
- PHE_Scientific_Provision of Fungitell kits, pipettes and assay plates - Variation 7 · 18 Mar 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.